2seventy bio Inc (TSVT)
4.76
-0.17
(-3.45%)
USD |
NASDAQ |
May 03, 16:00
4.76
0.00 (0.00%)
After-Hours: 20:00
2seventy bio Cash from Operations (Quarterly): -63.60M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -63.60M |
| September 30, 2023 | -21.51M |
| June 30, 2023 | -32.66M |
| March 31, 2023 | -49.09M |
| December 31, 2022 | -47.59M |
| September 30, 2022 | -60.61M |
| Date | Value |
|---|---|
| June 30, 2022 | -46.45M |
| March 31, 2022 | -73.48M |
| December 31, 2021 | -57.26M |
| September 30, 2021 | -43.35M |
| June 30, 2021 | -41.50M |
| March 31, 2021 | -64.75M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-73.48M
Minimum
Mar 2022
-21.51M
Maximum
Sep 2023
-50.15M
Average
-48.34M
Median
Cash from Operations (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 2.834B |
| Johnson & Johnson | 3.657B |
| Macrogenics Inc | -28.04M |
| Akebia Therapeutics Inc | -2.308M |
| Tango Therapeutics Inc | -27.47M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 47.89M |
| Cash from Financing (Quarterly) | 0.253M |
| Free Cash Flow | -180.72M |
| Free Cash Flow Per Share (Quarterly) | -1.258 |
| Free Cash Flow to Equity (Quarterly) | -64.67M |
| Free Cash Flow to Firm (Quarterly) | -64.67M |
| Free Cash Flow Yield | -77.08% |